Antiplatelet — COX Inhibitor
Pregnancy: D (third trimester, full dose)
Aspirin (Antiplatelet)
Brand names: Aspirin 75 mg, Anadin
Adult dose
Dose: 75 mg once daily (secondary prevention); 300 mg loading dose (acute arterial event)
Route: oral
Frequency: once daily
Max: 300 mg loading; 75 mg daily maintenance
Enteric-coated for GI protection (though evidence limited); take with food; do not use as primary prevention in low-risk patients
Paediatric dose
Dose: 5 mg/kg
Route: oral
Frequency: once daily
Max: 100 mg/day (Kawasaki), 75 mg/day (antiplatelet)
Kawasaki disease: 30–50 mg/kg/day in acute phase (max 4 g/day); reduce after fever resolves; AVOID in viral illness in children <16 years (Reye's syndrome)
Dose adjustments
Renal
Use with caution if eGFR <30 ml/min
Hepatic
Avoid in severe hepatic impairment (haemorrhagic risk)
Paediatric weight-based calculator
Kawasaki disease: 30–50 mg/kg/day in acute phase (max 4 g/day); reduce after fever resolves; AVOID in viral illness in children <16 years (Reye's syndrome)
Clinical pearls
- Irreversible COX-1 inhibition — effects last 7–10 days (platelet lifespan)
- ASPREE trial: primary prevention in elderly — more harm than benefit (bleeding > cardiovascular benefit)
- Aspirin resistance: up to 25% of patients (CYP2C19 polymorphism, compliance, drug interactions)
Contraindications
- Active peptic ulcer
- Haemophilia and other bleeding disorders
- Allergy/NSAID-induced asthma
- Children <16 years for viral illness (Reye's syndrome)
Side effects
- GI bleeding/ulceration
- Dyspepsia
- Bronchospasm (aspirin-sensitive asthma)
- Tinnitus (high dose)
- Rare: intracranial haemorrhage
Interactions
- NSAIDs (increased bleeding/gastropathy)
- Warfarin/DOACs (increased bleeding)
- SSRIs (increased GI bleed)
- Methotrexate (reduced clearance)
Monitoring
- Signs of GI bleeding
- Blood pressure
- Renal function (if CKD)
Reference: BNFc; BNF 86; NICE NG185; AHA guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DAPT Score · Coronary Artery Disease
- ARC-HBR Criteria for High Bleeding Risk in PCI · Coronary Artery Disease
- PRECISE-DAPT Score for Bleeding on DAPT · Coronary Artery Disease
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- DAPT Decision Tool (Ticagrelor vs Clopidogrel) · Antiplatelet Therapy
Pathways
- Peripheral Arterial Disease · NICE NG19 2012 / ESVS 2017
- Carotid Artery Disease · NICE CG68 / ESVS 2018
- Varicose Veins Management · NICE CG168 2013
- Venous Leg Ulcer Management · NICE NG204 2022
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185